COGNOPTIX

Cognoptix' goal is to provide clinicians with a highly accurate, reliable, inexpensive, convenient and widely available test that can be performed quickly on-site in the comfort of a physician's office, to enable swift intervention and early treatment... Cognoptix is developing an affordable, non-invasive screening test patients can take - in minutes - at their doctor's office... Drs. Chylack and Goldstein and their research team discovered that they could detect beta amyloid aggregates in the lens of the eye and that those proteins could be measured and monitored with non-invasive tools, such as existing laser eye scanning technologies. Further research determined that suspect beta amyloid proteins could be detected in the eye prior to buildup of toxic plaques in the brains of genetically engineered Alzheimer's mice. Cognoptix is currently developing combined optical scanning devices and diagnostic agents based on these discoveries for clinical, commercial and academic research use...

Also known as: Cognoptix Inc